Skip to Content

P-5377

Main Content

Blood | 2020

Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?

Shah NN, Ahn KW, Litovich C, He Y, Sauter C, Fenske TS, Hamadani M

PubMed
PMID: 33120429

Abstract
Related Articles

CIBMTR Study #: LY18-01b

Working Committee: Lymphoma

Dataset Files:
This dataset was collected by the Center for International Blood and Marrow Transplant Research (CIBMTR) which is supported primarily by the Public Health Service U24CA076518 from the National Cancer Institute; the National Heart, Lung, and Blood Institute; the National Institute of Allergy and Infectious Diseases; 75R60222C00011 from the Health Resources and Services Administration; N00014-23-1-2057 and N00014-24-1-2057 from the Office of Naval Research; NMDP; and the Medical College of Wisconsin. By downloading the dataset files below, you agree to the Terms and Conditions.
I agree to the Terms and Conditions; Download Dataset

I agree to the Terms and Conditions; Download Data Dictionary